Spain Ophthalmology Drugs & Devices Market Trends

Factors such as increasing glaucoma and awareness campaign are expected to increase the market growth. Furthermore, according to the data of the International Diabetes Federation, 2020, the estimated number of diabetic adults in Spain was around 3,619,100, which constitutes about 10.5% of the total population. Data from 100,734 ambulatory care visits and 11,408 hospital admissions related to glaucoma were acquired from the database, according to a research report released in January 2022 with the title "Ambulatory and hospital care of glaucoma in Spain and associated medical expenses." The majority of incidents involved patients who were over 65. Over the course of the study, ambulatory facilities had an incidence of glaucoma of 2.2 per 10,000 people, while hospitals had an incidence of 0.2 per 10,000 people. While the incidence of glaucoma reduced in hospitals over the research period, it considerably rose in ambulatory settings. The majority of hospital admissions and ambulatory visits were scheduled or not-urgent. The average annual cost per ambulatory visit was EUR 5.5 million; the average annual cost per hospital stay was EUR 4.1 million. Over the course of the study, the yearly cost of ambulatory care climbed dramatically while the annual cost of hospital care significantly reduced. Similarly, raising awareness about the early diagnosis of glaucoma and other disease diagnosis related to eye ocular pressure and the adoption of new products in the market further boost the growth of the studied market in Spain. For instance, in February 2021, Specsavers Ópticas has its Glaucoma 2021 campaign to raise awareness of the condition known as the silent thief of sight, which affects more than half a million people in Spain alone.